Journal News

From the journals: MCP

Shravanti  Suresh
July 7, 2021

Linking phosphorylation and synaptic vesicles recycling. How kinase responses affect plant development. Identifying protein interactions in prostate cancer. Read about papers on these topics recently published in the journal Molecular & Cellular Proteomics.

Linking phosphorylation and synaptic vesicles recycling

In the nervous system, signals are transmitted through cellular junctions known as synapses from presynaptic neurons to postsynaptic neurons. When an action potential arrives at the nerve terminal, the presynaptic neuron depolarizes and releases an influx of calcium ions through channels in the active zone. This connects the presynaptic neuron to the postsynaptic membrane. These fused synaptic vesicles, or SVs, need to be retrieved and recycled to sustain continuous neurotransmitter release and to maintain the structure and composition of the plasma membrane. Defects in these processes can cause neurological disorders.

Scientists have many hypotheses about the exact mechanism of this endocytosis and vesicle recycling. An increasing body of data points toward phosphorylation and dephosphorylation of proteins involved in the SV recycling as actions regulating this process. While some studies show an indirect relation between the two, changes in protein conformation that accompany assembly and disassembly of protein complexes during SV recycling may affect access to phosphorylation sites. Therefore, we cannot determine the effect of phosphorylation on SV recycling directly.

In a recent study published in the journal Molecular & Cellular Proteomics, Ivan Silbern and colleagues at the Max Planck Institute for Biological Chemistry, Germany, used botulinum neurotoxins, or BoNT, to differentiate between calcium-induced changes and phosphorylation events that are linked to SV recycling. By conducting a quantitative phosphoproteomic analysis using synaptosomes as a functional model for a synapse, they identified 1,500 sites that are affected by BoNT treatment, implying a direct connection to SV recycling. They also identified SV-cycling–dependent phosphorylation sites on syntaxin 1a, synaptobrevin and cannabinoid receptor 1.

This study demonstrates that the phosphorylation of these sites on the synaptosome can have a pronounced effect on exocytosis and endocytosis in cultured hippocampal neurons, establishing a firmer link between phosphorylation/dephosphorylation and SV recycling.

Neurons-890x712.jpg
S. Jeong/Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH
In mice with a mutation that causes the progressive neurodegenerative disease amyotrophic lateral sclerosis, a hyperactive enzyme called Cdk5 normally kills spinal cord neurons such as those pictured here.

How kinase responses affect plant development

Protein phosphorylation is an important mechanism that responds to environmental stimuli, especially in eukaryotes. Nearly 4% of the proteins encoded in Arabidopsis plants are protein kinases, suggesting a strong link to protein regulation. In plants, a serine/threonine protein kinase known as the Mut9-like kinase, or MLK, is linked to light, circadian and abiotic stress signaling. Previous studies have shown that MLKs provide a link between light and circadian signaling, which in turn affects plant growth and development. Researchers aim to identify roles of such kinases that use environmental inputs such as light and abiotic stress to generate altered developmental outputs.

In a recent paper in the journal Molecular & Cellular Proteomics, Margaret Wilson and colleagues at the Donald Danforth Plant Science Center describe using quantitative phosphoproteomics and global proteomic analysis to investigate the role of MLKs in daily protein dynamics. This study shows that in the absence of MLK, many proteins involved in light, circadian and hormone signaling as well as chromatin-modifying enzymes and DNA damage response factors have altered phosphorylation levels. Using several analytic methods, the authors showed that MLKs may help alleviate DNA damage through the regulation of multiple response pathways. They also observed higher levels of glucosinolate accumulation in MLK mutant plants, which could be related to the sensitivity to DNA-damaging agents. This is pivotal in understanding the role of MLK in multiple metabolic pathways that are regulated by this kinase in common.

Identifying protein interactions in prostate cancer

One in nine men are diagnosed with prostate cancer at some point in their lives. The growth and initiation of prostate cancer is caused by the androgen receptor, or AR, NR3C4, a steroid receptor. The AR acts as a transcriptional factor, regulating target genes involved in cell proliferation, survival and growth. While ARs are known to be regulated by several proteins affecting transcriptional location and ligand binding, researchers don’t know the extent of this regulation and aim to identify the AR protein interaction networks to understand better how prostate cancer starts and spreads.

In a recent paper in the journal Molecular & Cellular Proteomics, Lauriane Vélot and colleagues at the Centre de recherche sur le cancer de l’Université Laval, Quebec, write that they used BioID proximity labeling proteomics, which fuse a mutant biotin ligase with a protein of interest to deduce AR interactions. By applying this in androgen-dependent LAPC4 cells expressing wild-type AR, they were able to indicate precisely a network of 267 proteins, 213 of which had not been reported previously. The authors also identify Kruppel-like factor 4, or KLF4, as a new AR-associated protein that represses KLK3, commonly known as the prostate-specific antigen, without regulating AR expression. The authors speculate that by establishing high confidence interaction networks, they could learn about prostrate cancer’s complexity.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Shravanti  Suresh

Shravanti Suresh is a Ph.D. candidate in Dipali Sashital’s lab at Iowa State University and a volunteer ASBMB Today contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Sizing up cells: How stem cells know when to divide
News

Sizing up cells: How stem cells know when to divide

March 12, 2026

Stanford University researchers find that stem cells control their size early in cell division across living multicellular systems.

When oncogenes collide in brain development
Journal News

When oncogenes collide in brain development

March 10, 2026

Researchers at University Medical Center Hamburg, found that elevated oncoprotein levels within the Wnt pathway can disrupt the brain cell extracellular matrix, suggesting a new role for LIN28A in brain development.

The data that did not fit
Research Spotlight

The data that did not fit

March 5, 2026

Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.

Building a career in nutrition across continents
Profile

Building a career in nutrition across continents

March 3, 2026

Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.

Avoiding common figure errors in manuscript submissions
How-to

Avoiding common figure errors in manuscript submissions

Feb. 27, 2026

The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Journal News

Ragweed compound thwarts aggressive bladder and breast cancers

Feb. 26, 2026

Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.